Drug firm Aventis Pharma today said its net profit rose by 7.99 per cent to Rs 47.3 crore for the quarter ended September 30, 2010, over the same period last fiscal.
The company had a net profit of Rs 43.8 crore in the corresponding period of 2009-10, Aventis Pharma said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company climbed to Rs 275.6 crore for the quarter ended September 30, from Rs 258.5 crore in the same period last fiscal.
Shares of Aventis Pharma closed at Rs 1,811.40 on the BSE, down 1.25 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app